PRIMER

Serial Number 97002895
602

Registration Progress

Application Filed
Aug 30, 2021
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: PRIMER
Previous Owner: Arsenal Biosciences, Inc.
Classes: 005

Trademark Image

PRIMER

Basic Information

Serial Number
97002895
Filing Date
August 30, 2021
Abandonment Date
September 16, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Sep 30, 2024
Classes
005

Rights Holder

Arsenal Biosciences, Inc.

03
Address
329 Oyster Point Blvd.
South San Francisco, CA 94080

Ownership History

Arsenal Biosciences, Inc.

Original Applicant
03
South San Francisco, CA

Legal Representation

Attorney
R. Gwen Peterson

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

28 events
Date Code Type Description Documents
Sep 30, 2024 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Sep 30, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jun 13, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 13, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 13, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 3, 2024 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Nov 1, 2023 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Sep 29, 2023 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Sep 27, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 27, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 27, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 27, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 27, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 9, 2023 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Feb 13, 2023 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Feb 13, 2023 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jul 6, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jul 6, 2022 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Jul 6, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
May 10, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 9, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 9, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 11, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 11, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 11, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 3, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 13, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 2, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biologics for medical use, namely, biological preparations for the assessment of treatment options for, and the treatment and prophylaxis of, solid tumors and oncological diseases, disorders and conditions; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of solid tumors; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of oncological and infectious diseases, disorders and conditions; biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions

Classification

International Classes
005